Todd Rosengarten is the leader of the non-small molecule CMC development, technical operations, and manufacturing practice at Klein Hersh. He joined Klein Hersh in 2008 and has driven the growth of the practice, working closely with large biopharma companies and small biotechs developing cell and gene therapy products and novel biologics drugs.
As the leader of the non-small molecule CMC development, technical operations, and manufacturing practice, Todd’s responsibilities include:
- Partnering with large biopharma companies, small biotechs, and contract development & manufacturing organizations (CDMOs) on the recruitment of senior operational and technical leadership executives to lead products out of discovery and into the clinic, helping to ensure clinical supply, eventual commercial launch, and on-going commercial support.
Todd also co-leads Klein Hersh’s tools, technology, and services practice, helping those businesses find broad organizational leadership, including CEO, CCO, COO, CTO, and CBO roles. His responsibilities also include Board of Directors and SAB construction.
Each year, Todd is an attendee and participant at ASGCT, Meeting on the Mesa, BIO, and Phacilitates Cell and Gene Therapy conferences.
